Skip to content
Home/Companies/HealthTech/Fytexia
FY

Fytexia

HealthTech·France·Exited 2023·Held 7yr

Fytexia is a consumer health company, headquartered in France.

Entry
2016
Hold
7yr
Exit
2023
Est. EV
–

Who owns Fytexia?

Fytexia was owned by ARCHIMED through MED I (2014 vintage) from 2016 to 2023, exited via Trade Sale.

Buyer identity and MOIC available on Pro.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED I · 2014 · Buyout

Key facts

HQFrance
SectorConsumer Health
Exit Type
Trade Sale
Buyer
MOIC
Exit Year
2023

More from MED I

Other portfolio companies in the same fund.

Esperion Therapeutics
Active
Stago
Active
MedTechFrance· 2026
Micromed
Exited 2023
MedTechFrance· 2016
to
Natural Origins
Exited 2017
HealthTechFrance· 2016
to
Polyplus
Exited 2023
BiotechFrance· 2016
to
Deallus
Exited 2024
PharmaUK· 2015
to

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

CIGA Healthcare
Active
Clarendon Fund ManagersUK
Paladin
Active
Ring CapitalFrance
Theraclion
Exited 2014
KaristaFrance
to
Access Infinity
Active
CBPE CapitalUK· 2026
Brightheart
Active
Odyssée VentureFrance· 2026
Dermascan
Active
Ring CapitalFrance· 2026
Data refreshed weekly · Sourced from public filings